Semaglutide – 5mg-10mg

Semaglutide

Semaglutide is a potent synthetic analog of the endogenous human incretin hormone, Glucagon-Like Peptide-1 (GLP-1). In the field of advanced metabolic and endocrinology research, Semaglutide is a cornerstone compound for investigating glycemic control, weight management, and cardiovascular risk reduction. Engineered for enhanced stability, its structure includes a specific fatty acid side chain that allows for high albumin binding and significant resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4). This modification provides researchers with a long-acting experimental model to study sustained GLP-1 receptor activation and its multifaceted effects on insulin secretion, glucagon suppression, and delayed gastric emptying.

Our Semaglutide is synthesized in an ISO 9001:2015 certified and GMP-grade manufacturing environment. By utilizing state-of-the-art solid-phase synthesis and rigorous multi-stage HPLC purification, we achieve an ultra-high chemical purity of ≥99%. This meticulous production standard ensures the peptide is free from truncated sequences and residual chemical catalysts, providing the high-fidelity results necessary for accurate studies into receptor binding affinity and long-term metabolic signaling.

Research Applications & Mechanisms

Incretin System Modulation

Investigating the potentiation of glucose-dependent insulin secretion and the regulation of pancreatic beta-cell function in experimental diabetic models.

Central Appetite Regulation

Researching the peptide’s interaction with GLP-1 receptors in the hypothalamus and hindbrain to study its influence on satiety signaling and food intake behavior.

Adipose Tissue & Lipid Metabolism

Studying the mechanisms through which sustained GLP-1 activation influences lipogenesis, fat oxidation, and visceral adipose tissue reduction.

Cardiovascular & Renal Signaling

Exploring the potential anti-inflammatory and protective effects of Semaglutide in vascular and renal epithelial cell research models.

Technical Specifications

Key Features & Quality Assurance

Pharmaceutical-Grade Lyophilization

Our proprietary vacuum-sealing process ensures the Semaglutide powder surface is perfectly smooth, flat, and delicate. This uniform “cake” structure ensures rapid reconstitution and maintains the structural integrity of the complex fatty acid-linked peptide chain.

Superior Molecular Stability

The specific chemical modifications of our synthetic Semaglutide ensure a high resistance to proteolytic cleavage, allowing for extended observation windows in both in-vitro and in-vivo research designs.

Reconstitution & Storage

Reconstitution Guide

• Preparation: Allow the vial to reach room temperature. Centrifuge for 30-60 seconds to ensure the Semaglutide cake is at the base.

• Solvent: Reconstitute with Sterile Water or Bacteriostatic Water.

• Technique: Gently introduce the diluent against the vial wall. DO NOT SHAKE; swirl gently until the solution is clear and transparent.

Storage Protocols

• Long-term: Store at -20°C (Maintains potency for up to 24 months).

• Short-term: Stable at 2–8°C for up to 3 months.

• Post-Reconstitution: Store at 2–8°C and utilize within 14-21 days for optimal results.

Shipping & Documentation

• Global Logistics: Shipped in discreet, temperature-controlled packaging to protect the Semaglutide molecular structure.

• Verified Quality: A batch-specific Certificate of Analysis (COA) and HPLC/MS reports are available for every order.

• Reshipment Policy: We provide a guaranteed reshipment policy for any lost or customs-intercepted orders ().

⚠️ Research Disclaimer

Product-Specific Safety Notice: This Semaglutide is strictly for laboratory research and analytical purposes. It is NOT intended for human or veterinary administration. All research must be conducted by qualified professionals.

Scientific Resources & References

• PubMed – NIH:

• ScienceDirect (Elsevier):

🔍 Deep Dive Research

• [Technical Guide]: How to Reconstitute and Store Lyophilized Peptides for Maximum Potency

• [Metabolic Study]: Beyond Glucose Control: The Role of Semaglutide in Adipose Tissue Research